Novel antibody formulation

Details for Australian Patent Application No. 2009294680 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Grauschopf, Ulla; Mahler, HannsChristian; Stauch, Oliver Boris

Agent Spruson & Ferguson

Pub. Number AU-A-2009294680

PCT Pub. Number WO2010/031720

Priority 08164746.3 19.09.08 EP

Filing date 9 September 2009

Wipo publication date 25 March 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/031720 Priority application(s): WO2010/031720

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009294695-Piperazine D3 and 5-HT2a receptor modulators

2009294678-Multi-layered lignocellulosic molded bodies with low formaldehyde emissions